Scientists Intrigued by Treatment That Put Every Single Patient's Cancer Into Remission

Brasil Notícia Notícia

Scientists Intrigued by Treatment That Put Every Single Patient's Cancer Into Remission
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 futurism
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 68%

'I believe this is the first time this has happened in the history of cancer.'

an MSK press release about the study describes

The first patient, named Sascha, was preparing to travel to New York to have radiation therapy when she got the call from her oncologist, Andrea Cercek, who said the patient was "stunned and ecstatic" at the news. The MSK doctors behind the study wanted to investigate whether immunotherapy alone could treat cancer, but they never expected it to work this well — and especially could not have foreseen that none of the 12 people in the initial trial had adverse reactions to the drug, known as dostarlimab.

Dr. Alan Venook, a University of California, San Francisco colorectal cancer specialist who wasn't involved in the study, told thethat the lack of side effects means that "either they did not treat enough patients or, somehow, these cancers are just plain different."

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

futurism /  🏆 85. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

'I've been let down - I shouldn't have stage-4 cancer''I've been let down - I shouldn't have stage-4 cancer'Caroline Boulton says there have been delays at every stage of her treatment for breast cancer.
Consulte Mais informação »

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial - Nature MedicineTrastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial - Nature MedicineFindings from the TUXEDO-1 trial demonstrate efficacy of the antibody-drug conjugate trastuzumab deruxtecan for treatment of brain metastases in patients with HER2-positive BreastCancer. CNS Cancer NMEDClinical MedUni_Wien
Consulte Mais informação »

Climate of Fear: Texas study shows how abortion bans put high-risk patients in jeopardyClimate of Fear: Texas study shows how abortion bans put high-risk patients in jeopardyResearchers found that some Texas patients needed to be in danger of death before medical providers were willing to terminate the pregnancies putting their lives at risk. AbortionRightsAreHumanRights AbortionBan Texas RoeVWade abortions GregAbbott
Consulte Mais informação »

A new small and less costly molecule could make immunotherapy available to all cancer patientsA new small and less costly molecule could make immunotherapy available to all cancer patientsResearchers came up with a small molecule, which will be a less costly and more effective alternate to an antibody that can treat various types of cancers.
Consulte Mais informação »

How a 9-year-old Texas girl's fight against a rare cancer made her a TikTok starHow a 9-year-old Texas girl's fight against a rare cancer made her a TikTok starMae Gerdsen, 9, is now in remission after being diagnosed with a rare form of cancer. She and her mother shared their daily journey through treatment on TikTok.
Consulte Mais informação »



Render Time: 2025-03-01 17:20:53